Two MHL players suspended
by Martin Merk|10 JUL 2020
share
The IIHF has suspended the two Russian junior players Anton Borodkin and Nikolai Shashkov for eight months after positive doping tests in the Russian junior league MHL.

The IIHF is granted control over the doping control testing and test planning of the Russian-based Kontinental Hockey League, to which the MHL belongs.

Sarmaty Orenburg goaltender Anton Borodkin was tested after the game against Tolpar Ufa on 16 February. The laboratory found the presence of 5-methylhexan-2-amine, a prohibited substance listed on the 2020 WADA Prohibited List under S6b Stimulants as a specified substance.

In his explanation the player alleged that he used a pre-workout supplement, which showed the presence of the prohibited stimulant, on the day before the doping control. Based on the estimated concentration of the prohibited substance found in the player’s urine and the player’s explanation, the IIHF was of the opinion that the violation was not intentional and that the prohibited substance was ingested out of competition. As the substance is only prohibited in-competition, the player’s fault therefore merely lied in the fact that he returned to competition prior to the substance being cleared from his system for in-competition doping control.

Moreover, the IIHF took into account the player’s youth and inexperience, and the lack of anti-doping education received by the player. Accordingly, the IIHF deemed an eight-month period of ineligibility to be appropriate.

The player waived his right to disciplinary proceedings including a formal hearing and accepted an eight-month period of ineligibility starting on 16 February 2020.

Stalnye Lisy Magnitogorsk goaltender Nikolai Shashkov was tested on 13 March following the game against Tolpar Ufa. The laboratory found the presence of tuaminoheptane, a prohibited substance listed on the 2020 WADA Prohibited List under S6b Stimulants as a specified substance.

The player indicated that he used a nasal spray in the evening before the game without verifying the product for a prohibited substance or checking with the team doctor.

The IIHF was of the opinion that the violation was not intentional and that, based on the concentration of tuaminoheptane found in his urine, the prohibited substance was taken at least 12 hours before the start of the game and thus out of competition. As Tuaminoheptane is only prohibited in-competition, the player’s fault lied either in the fact that he took the substance too close to the start of his game or that he did not wait long enough to return to competition after ingesting the substance to ensure that the prohibited substance timely exited his body for in-competition doping control purposes.

The IIHF considered that the player committed the violation with no significant fault and that a normal degree of fault can be attributed, and took into account the player’s youth and inexperience, and the lack of anti-doping education received.

The IIHF suspended the player for eight months. The player waived his right to disciplinary proceedings including a formal hearing and accepted an eight-month period of ineligibility starting on 13 March 2020.